TocilizuMab discontinuAtion in GIant Cell Arteritis
Clinical trial NCT06037460 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06037460
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2027-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.